loading
Schlusskurs vom Vortag:
$3.63
Offen:
$3.63
24-Stunden-Volumen:
2.52M
Relative Volume:
1.32
Marktkapitalisierung:
$636.06M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.325
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
+6.00%
1M Leistung:
+16.30%
6M Leistung:
-24.59%
1J Leistung:
-57.84%
1-Tages-Spanne:
Value
$3.61
$3.73
1-Wochen-Bereich:
Value
$3.50
$3.82
52-Wochen-Spanne:
Value
$1.775
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Firmenname
Relay Therapeutics Inc
Name
Telefon
617-370-8837
Name
Adresse
399 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
259
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RLAY
Relay Therapeutics Inc
3.71 600.06M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-17 Eingeleitet Wells Fargo Equal Weight
2024-09-10 Fortgesetzt Goldman Buy
2024-09-10 Hochstufung Jefferies Hold → Buy
2024-09-10 Herabstufung Oppenheimer Outperform → Perform
2024-05-10 Hochstufung Barclays Equal Weight → Overweight
2023-04-20 Hochstufung Jefferies Underperform → Hold
2023-04-19 Hochstufung Raymond James Outperform → Strong Buy
2023-04-13 Eingeleitet Raymond James Outperform
2023-02-03 Eingeleitet Oppenheimer Outperform
2022-09-30 Eingeleitet Barclays Equal Weight
2022-09-02 Eingeleitet Stifel Buy
2022-06-06 Eingeleitet Jefferies Underperform
2022-02-01 Eingeleitet Berenberg Buy
2021-07-21 Eingeleitet BofA Securities Buy
2020-12-15 Bestätigt H.C. Wainwright Buy
2020-12-08 Eingeleitet JMP Securities Mkt Outperform
2020-11-05 Eingeleitet H.C. Wainwright Buy
2020-08-10 Eingeleitet Cowen Outperform
2020-08-10 Eingeleitet Goldman Buy
2020-08-10 Eingeleitet Guggenheim Buy
2020-08-10 Eingeleitet JP Morgan Neutral
Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Relay Therapeutics Inc. stockExceptional return forecasts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Relay Therapeutics Inc. stock priceFree Daily Trading Room Entry - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Relay Therapeutics Inc. a good long term investmentUnprecedented growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Relay Therapeutics Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

what makes relay therapeutics inc. stock price move sharplyTargeted 200 Percent Gain - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Relay Therapeutics Inc. stock overhyped or has real potentialLong Term Secure Gain Stocks - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Relay Therapeutics Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

RLAY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

How Relay Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Relay Therapeutics Inc. stock price move sharplyTrade Ready Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

DekaBank Deutsche Girozentrale Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Jul 15, 2025
pulisher
Jul 12, 2025

Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st

Jul 12, 2025
pulisher
Jul 12, 2025

Wealth Enhancement Advisory Services LLC Makes New $41,000 Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

AI drug discovery platform Market May See a Big Move | Major Giants - openPR.com

Jul 11, 2025
pulisher
Jul 10, 2025

Relay Therapeutics CEO Patel sells $219k in shares By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 05, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? - The Globe and Mail

Jul 02, 2025
pulisher
Jun 24, 2025

Relay Therapeutics: A Biotech Breakthrough with Momentum - AInvest

Jun 24, 2025
pulisher
Jun 23, 2025

13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 23, 2025
pulisher
Jun 20, 2025

With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - PR Newswire

Jun 20, 2025
pulisher
Jun 19, 2025

Unraveling Relay Therapeutics' 9.8% Spike: A Closer Look at the Anomaly - AInvest

Jun 19, 2025
pulisher
Jun 18, 2025

In the Green: Relay Therapeutics Inc (RLAY) Closes at 3.06, Up/Down -6.42 from Previous Day - DWinneX

Jun 18, 2025
pulisher
Jun 14, 2025

Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com India

Jun 14, 2025
pulisher
Jun 12, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors | RLAY Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Relay Therapeutics Appoints Claire Mazumdar to Board of Directors - citybiz

Jun 11, 2025
pulisher
Jun 11, 2025

# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Relay Therapeutics Appoints Claire Mazumdar To Board Of Directors - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 9,293 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Jun 11, 2025

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):